The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 741 through 750 of 961 results (Download Results)

Show results per page

Rapid development of antiviral compounds to fight the COVID‑19 outbreak

Sidhu, Sachdev S | University of Toronto | Operating Grant | $886,090

CIHR Ontario 2020

Interventions to Mitigate COVID‑19 Related Mental Health Risks for Those With Pre-Existing Chronic Health Conditions and Facing Social and Economic Barriers: A Scoping and Rapid Realist Review

Davison, Karen M | Kwantlen Polytechnic University | Operating Grant | $50,000

CIHR British Columbia 2020

Development of field-deployable and point-of-need diagnostics for SARS-CoV-2 using CRISPR-based technology

Pickering, Bradley | Canadian Science Centre for Human and Animal Health | Operating Grant | $411,820

CIHR Manitoba 2020

RIsk of environmental Surface and air Contamination in COVID19 (RISC-COV)

McGeer, Allison J | Sinai Health System | Operating Grant | $493,140

CIHR Ontario 2020

Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

Lemieux, Joanne M | University of Alberta | Operating Grant | $585,228

CIHR Alberta 2020

Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $999,356

CIHR Ontario 2020

Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Liang, Chen | Lady Davis Institute for Medical Research | Operating Grant | $480,000

CIHR Quebec 2020

Scalable, Customizable, Digital Health Communication Materials to Help Canada Address the COVID19 Pandemic

Witteman, Holly M | Université Laval | Operating Grant | $311,296

CIHR Quebec 2020

Engage-COVID-19: A mixed methods study of biomedical, behavioural, and psychosocial aspects of the COVID‑19 pandemic among gay, bisexual, and other men who have sex with men in Canada

Grace, Daniel | University of Toronto | Operating Grant | $687,901

CIHR Ontario 2020

Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection

Lemieux, Joanne M | University of Alberta | Operating Grant | $714,250

CIHR Alberta 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Rapid development of antiviral compounds to fight the COVID‑19 outbreak

Interventions to Mitigate COVID‑19 Related Mental Health Risks for Those With Pre-Existing Chronic Health Conditions and Facing Social and Economic Barriers: A Scoping and Rapid Realist Review

Development of field-deployable and point-of-need diagnostics for SARS-CoV-2 using CRISPR-based technology

RIsk of environmental Surface and air Contamination in COVID19 (RISC-COV)

Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Scalable, Customizable, Digital Health Communication Materials to Help Canada Address the COVID19 Pandemic

Engage-COVID-19: A mixed methods study of biomedical, behavioural, and psychosocial aspects of the COVID‑19 pandemic among gay, bisexual, and other men who have sex with men in Canada

Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection